The Blue Eye submucosal injection agent has received FDA clearance and is now available in the U.S. The product, manufactured by Korean devicemaker the Standard Company, is used in endoscopic ...
Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
The figure was derived from‘International consensus on the management of large (≥20 mm) non-pedunculated colorectal polyps: A World Endoscopy Organisation Delphi study’; Djinbachian et al, 2023; Under ...
Active ingredient: Dextranomer microspheres 50 mg/mL, sodium hyaluronate 15 mg/mL; gel for submucosal injection. Indication: Treatment of fecal incontinence in patients who have failed conservative ...
Colorectal cancer (CRC) is the second most common cancer in the United States. This highlights the importance of early detection and treatment of precancerous lesions like large polyps. Endoscopy ...
Olympus Europa SE & Co. KG is launching three Endoclot products, two hemostatic agents and a submucosal injection agent, in the Europe, Middle East and Africa (EMEA) region. This new portfolio was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results